the aid library

LIST OPTIONS

Filter

327

Sort by:

Direction:

Download (280)

View PDF (441)

Public information on biological and chemical threats (English/Arabic)

World Health Organization (WHO) (2003) C_WHO

The purpose of this document is to inform the public about biological and chemical hazards and thereby prepare the population for an immediate response in the event of an incident until public health support is provided. The agents reported here are: Anthrax, Botulism, Haemorrhagic Fever, ... more

Download (2381)

View PDF (1416)

National Standard Therapeutic Guidelines and Essential Medicines List Liberia 2017, 2nd ed.
recommended

Republic of Libera, Ministry for Health and Social Welfare (2017) C1

Download (484)

View PDF (853)

Access to and Quality of Menstrual Regulation and Postabortion Care in Bangladesh: Evdence from a Survey of Health Facilities, 2014

Altaf Hossain, Isaac Maddow-Zimet, Meghan Ingerick et al. Guttmacher Institute (2017) C1

Download (257)

View PDF (288)

Introduction to Low Cost Sanitation
recommended

Centre for Affordable Water and Sanitation Technology CAWST (2011) CC

Planning, Promotion, Contruction & Design. Manual

Download (633)

View PDF (1360)

GUIDELINES FOR THE MANAGEMENT, PREVENTION & CONTROL OF MENINGOCOCCAL DISEASE IN SOUTH AFRICA

Dept. of Health, Republic of South Africa (2011) C1

Download (509)

View PDF (551)

Water, Sanitation and Hygiene Guidelines

Mercy Corps USAID (2009) C1

Download (6342)

View PDF (4235)

Wound Care For People Affected by Leprosy: A Guide for Low Resource Situations

Hugh Cross American Leprosy Mission (2003)

A Guide for Low Resource Situations

Download (509)

View PDF (1216)

Uganda: The National Policy Guidelines and Service Standards for Reproductive Health Services

Reproductive Health Division Community Health Department Ministry of Health Uganda (2002)

Download (11606)

View PDF (2436)

Minor Surgical Procedures in Remote Areas
recommended

Médecins sans Frontières (1989) C2

Download (111)

View PDF (144)

National Guideline for Health Care Provider On Infection Prevention and Control of COVID-19 pandemic in Healthcare Setting

Ministry of Health & Family Welfare of Bangladesh, Directorate General of Health Services Ministry of Health & Family Welfare of Bangladesh, Directorate General of Health Services (2020) C2

Version: 2.0 Date: 19.3.2020

Download (39)

View PDF (41)

Prevalence, Etiology, and Outcome of Sepsis among Critically Ill Patients in Malawi

Prin, M.; Onofrey, L.; Purcell, L; et al. (2020) CC2

Most of the global burden of sepsis occurs in low- and middle-income countries (LMICs), but the prevalence and etiology of sepsis in LMICs are not well understood. In particular, the lack of laboratory infrastructure in many LMICs has historically precluded an assessment of the pathogens leading to ... more

Download (58)

View PDF (35)

Antimicrobial Resistance Curriculum Assessment Tool for Medical Education

World Health Organisation (WHO) (2024) C_WHO

The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ... more

Download (81)

View PDF (140)

Addressing gender inequalities in national action plans on antimicrobial resistance

World Health Organisation (WHO) (2024) C_WHO

National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.

Download (261)

View PDF (356)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (158)

View PDF (142)

Public health resource pack for countries experiencing outbreaks of influenza in animals: revised guidance

World Health Organisation (WHO) (2023) C_WHO

This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the key information needed for advising their Member States in response to questions raised on human health due to influenza outbreaks or detections in... more

Download (88)

View PDF (434)

Scabies epidemiology in health care centers for refugees and asylum seekers in Greece

Louka, C.; Logothetis, E.; Engelman, D. et al. PLoS Neglected Tropical diseases (2022) CC

Scabies is a global health concern disproportionately affecting vulnerable populations such as refugees and asylum seekers. Greece is a main point of entry in Europe for refugees, but epidemiological data on scabies in this population are scarce. We aimed to describe the epidemiology of scabies, inc... more

Download (461)

View PDF (815)

Antimicrobial Stewardship Program Guideline (India)
recommended

Balaji, V., P. Rupali, K. Walia, et al. Indian Council of Medical Research (2018) C2

Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o... more

Download (130)

View PDF (666)

Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic review

Van Dijck C., Vlieghe E., Cox J.A. Bulletin of the World Health Organization (2018) C_WHO

Objective: To review the effectiveness of antibiotic stewardship interventions in hospitals in low- and middle-income countries.

Download (218)

View PDF (238)

Tool for the diagnosis and care of patients with suspected arboviral diseases

Pan American Health Organization PAHO ; World Health Organization WHO (2017) C_WHO

It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10... more

Download (150)

View PDF (259)

Bahrain - National Action Plan on Antimicrobial Resistance

Kingdom of Bahrain - Ministry of Health (2019) C2

In the kingdom of Bahrain, the national antibiotic committee will set the framework for the national response to AMR, especially bacterial resistance to antibiotics. It will be aligned with the World Health Organization’s (WHO) Global Action Plan on Antimicrobial Resistance, and with standards and... more

National Standard Therapeutic Guidelines and Essential Medicines List Liberia 2017, 2nd ed. recommended

Introduction to Low Cost Sanitation recommended

Minor Surgical Procedures in Remote Areas recommended

Antimicrobial Stewardship Program Guideline (India) recommended

National Standard Therapeutic Guidelines and Essential Medicines List Liberia 2017, 2nd ed.
recommended

Introduction to Low Cost Sanitation
recommended

Minor Surgical Procedures in Remote Areas
recommended

Antimicrobial Stewardship Program Guideline (India)
recommended